Infection density, inflammatory disease, and treatment in CT (non-HCT) and HCT-treated patients. Frequency of total infections (A), CGD infections (B), bacterial infections (C), and fungal infections (D); the use of antibacterial prophylaxis (E), antifungal prophylaxis (F), and IFN-γ (G); the frequency of total inflammatory disease (H) and inflammatory bowel disease (I); and the use of systemic steroids (J) are shown in CT (non-HCT) and HCT-treated patients before HCT and at 1, 2, and 3 to 5 years after HCT. P values compare CT (non-HCT) time point with pre-HCT (HCT baseline), CT with post-HCT time point of 3 to 5 years, and pre-HCT with post-HCT time point of 3 to 5 years.